Assistant Professor

Radiation Oncology

Cullen Taniguchi practices Radiation Oncology. He studied medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School has a rank of 1 in research and a 12 in primary care Cullen Taniguchi has written publications. He has 14 publications published with PubMed. The lastest paper is: 'PHD Inhibition Mitigates and Protects Against Radiation-Induced Gastrointestinal Toxicity via HIF2.' He accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• PHD Inhibition Mitigates and Protects Against Radiation-Induced Gastrointestinal Toxicity via HIF2.
• Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.
• A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition.
• Dosimetric Analysis of Organs at Risk During Expiratory Gating in Stereotactic Body Radiation Therapy for Pancreatic Cancer.
• The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.
• The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance.
• Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.
• Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta.
• Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.
• New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure.
• Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin.
• Critical nodes in signalling pathways: insights into insulin action.
• Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a mod...

Schools

---

• Harvard Medical School

Doctors Specialties

---

• Radiation Oncology

Accepted Insurances

---

• Aetna HMO
• Choice Plus POS II
• Blue Card PPO
• Blue Choice
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• LocalPlus
• Open Access Plus
• Choice Care PPO
• MultiPlan PPO
• PHCS Network PPO
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO

Education

---

• Stanford University
• Santa Clara Valley Medical Center
• Harvard Medical School

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1144495623
Last Name Of The Provider	TANIGUCHI
First Name Of The Provider	CULLEN
View All

Similar Doctors

---

	Dr. Thomas J. Pugh, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel C. Garner, MD This Doctor is OpenDoctor Recommended.
	Dr. Ivan L. Kessel, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel R. Gomez, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. David R. Grosshans, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Robert S. Bradfield, MD This Doctor is OpenDoctor Recommended.
	Dr. Beverly A. Guadagnolo, MD This Doctor is OpenDoctor Recommended.
	Dr. Melenda D. Jeter, MD This Doctor is OpenDoctor Recommended.
	Dr. John S. Yordy, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian J. Deegan, MD
	Dr. Nora A. Janjan, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. James C. Marbach, MD
	Dr. Elisabeth Kelly, MD This Doctor is OpenDoctor Recommended.
	Dr. Luka Milas, MD This Doctor is OpenDoctor Recommended.
	Dr. Corey W. Speers, MD This Doctor is OpenDoctor Recommended.
	Dr. Cameron H. Swanick, MD This Doctor is OpenDoctor Recommended.
	Dr. Chisaroka W. Echendu, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog